Filter by
Clear filters
San Francisco.
FROM Jan 25th 2025 TO Jan 30th 2025
BiOS & PHOTONICS WEST 2025
SPIE BiOS and Photonics West, two must-attend events for lasers, biomedical optics and biophotonic technologies, quantum, and optoelectronics.
Oct 28th 2024
9M 2024 Results
Exosens (Ticker: EXENS – ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, today announces its revenue and adjusted gross margin for the nine-month period ended 30 September 2024.
Oct 22nd 2024
Exosens announces agreement to acquire NVLS
Exosens announces agreement to acquire NVLS (Night Vision Laser Spain), specialist in night vision equipment
Pacifico Yokohama.
FROM Dec 04th 2024 TO Dec 06th 2024
ITE JAPAN 2024
Visit Exosens at ITE JAPAN 2024 in Pacifico Yokohama. Exosens will be presenting its extensive expertise in cutting-edge imaging technologies, spanning UV to LWIR wavelengths.
Oct 11th 2024
Photonis selected for UK MoD contract
Exosens’ subsidiary Photonis wins key role in UK MoD’s Talon fused weapon sight contract
Sep 26th 2024
Exosens invests in Meteor programme with Leicester’s Space Park
Exosens invests £1m to propel space research and innovation for the Meteor programme in partnership with Leicester’s Space Park
Sep 12th 2024
Xenics expands its advanced imaging portfolio
Xenics expands its advanced imaging portfolio with launch of cheetah+ series
Sep 10th 2024
Exosens and Theon have signed a multi-year image intensifier tubes delivery agreement
Exosens and Theon International frame their long-term commercial relationship to cover night vision devices business
Sep 03rd 2024
H1 2024 Results
Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, today announces its results for the half-year ended 30 June 2024.
Sep 02nd 2024
Exosens completes the acquisition of LR Tech
Exosens completes the acquisition of LR Tech, leader in spectroradiometer based solutions
Tshwane, South Africa.
FROM Sep 18th 2024 TO Sep 29th 2024
AAD 2024
Visit Photonis at AAD 2024 from 18 to 29 September 2024 in Tshwane, South Africa
World Trade Center Metro Manila, Philippines.
FROM Sep 25th 2024 TO Sep 27th 2024
ADAS 2024
Visit Exosens at ADAS 2024 from 25 to 27 September 2024 in Metro Manila, Philippines
Aug 01st 2024
Exosens Completes The Closing Of The Acquisition Of Centronic, Leader In Radiation Detection Solutions
Exosens announces the closing of the acquisition of UK-based Centronic, a specialist in radiation detectors and devices.
Jul 30th 2024
Photonis Showcases Advanced Nuclear Instrumentation Solutions At Utility Working Conference
Photonis, part of Exosens, a leading global provider of neutron and gamma detectors for the nuclear industry, announces its participation at the American Nuclear Society’s Utility Working Conference and Vendor Technology Expo.
Jul 29th 2024
Photonis Delivers 4G+ Image Intensifier Tubes To Boost Australian Army Vision
Photonis, part of Exosens, world leading manufacturer of image intensifier tubes, has supplied cutting-edge 4G+ P45 (white phosphor) 18mm image intensifier tubes to Theon Sensors for integration by its local partner Force Ordnance (Australia)...
Stuttgart, Germany.
FROM Oct 08th 2024 TO Oct 10th 2024
VISION 2024
Visit Exosens at VISION 2024 - Booth 8C26, Hall 8 in Stuttgart. VISION 2024 is the world’s leading exhibition for machine vision technologies and system integrators.
Jul 24th 2024
Strong first half 2024 revenue with continuing growth Momentum
Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology components, achieved consolidated revenue of €186.9 million for the first half 2024.
Jul 08th 2024
Exosens announces the implementation of a liquidity contract with Kepler Cheuvreux
EXOSENS S.A. (Euronext Paris: FR001400Q9V2) announces today the implementation of a liquidity agreement with Kepler Cheuvreux to enhance the liquidity of EXOSENS shares admitted to trading on Euronext Paris....